Skip to main content

Table 2 Medication profile of heart failure patients based on ejection fraction

From: Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study

Medication LVEF ≥ 50 (n,164) LVEF < 50% (n,147) P value
ACEI n, % 34 (15.85) 80 (40.82) <0.001
Beta Blocker n, % 45 (21.95) 73 (36.73) <0.001
Diuretics n, % 146 (74.39) 136 (70.75) 0.290
Spironolactone n, % 114 (57.93) 95 (48.99) 0.359
Digoxin n, % 46 (23.17) 33 (17.69) 0.257
Statin n, % 24 (11.59) 30 (13.61) 0.180
Anticoagulants n, % 33 (17.07) 12 (14.70) 0.003
Antiplatelet agents n, % 33 (15.24) 39 (17.69) 0.181
CCB n, % 21 (9.76) 7 (4.76) 0.013
  1. ACEI angiotensin converting enzyme inhibitor, CCB calcium channel blocker